GENEVA (HRNW) – The Pfizer/BioNTech vaccine has been authorised for use in Switzerland following a two-month rolling review, the Swissmedic regulatory authority said Sunday.
“After a meticulous review of the available information, Swissmedic concluded that the Covid-19 vaccine from Pfizer/BioNTech is safe and that its benefit outweighs the risks,” the body said in a statement.
Be the first to comment on "Swiss authorise Pfizer/BioNTech Covid-19 vaccine"